Corporate report

Register of interests

Updated 16 November 2020

1. Professor Judith Aldridge

Professor of Criminology, University of Manchester

Declaration of interests

• George Soros Visiting Chair, School of Public Policy, Central European University (2017)
• Collaborator, Centre International de Criminologie Comparée (CICC), University of Montreal
• Member of the International Society for the Study of Drug Policy, European Society of Criminology
• Editorial Board, Addiction, Research and Theory; Drugs: Education, Prevention and Policy
• Advisory Board, Recovering Justice UK
• Advisory work, European Commission, Pompidou Group of the Council of Europe, EMCDDA
• Consultancy services provided to Release UK
• Research funding received from:
  • UK Research Councils
  • Nuffield
  • Ministry of Justice (the Netherlands)
  • NESTA
  • Manchester City Council
  • Home Office

2. Dr Kostas Agath

Consultant Psychiatrist (addictions), Change Grow Live (CGL) Southwark

Declaration of interests

• Former Financial Officer of the Executive of the Addictions Faculty (Royal College of Psychiatrists)
• Former Financial Officer of the Executive of London Division (Royal College of Psychiatrists)
• Former member of the Expert Advisory Group for Substance Misuse at the Care Quality Commission (CQC)
• Former Lead Governor of the College of North West London NHS Foundation Trust
• Former Medical Director of Addaction

3. Professor Owen Bowden-Jones

Consultant psychiatrist, Central North West London NHS Foundation Trust and Honorary Professor, University College London

Declaration of interests

• Clinical Lead, College of North West London Club Drug Clinic
• Chair and Clinical Lead, NEPTUNE clinical guidance
• Clinical Adviser, Public Health England (PHE)
• Private medical practice
• Research funding received from:
  • The Health Foundation
  • United Nations Office on Drugs and Crime (UNODC)
  • European Monitoring Centre for Drugs and Drug Addiction (EMCDDA)

4. Dr Anne Campbell

Lecturer in Social Work, Queens University Belfast

Declaration of interests

• National Institute of Drug Abuse (US) Life time International Fellow
• Member of the Treatment and Support Advisory Committee, Northern Ireland Department of Health
• Member of the Northern Ireland Strategy Outcomes Writing Group for new Northern Ireland Policy on Alcohol and Drugs, Northern Ireland Department of Health
• Co-Director of the Drug and Alcohol Network (DARN), Queens University Belfast
• Board Member of Ascert, (Community Drug and Alcohol service provider in Northern Ireland)
• Extern, (Community Drug and Alcohol service provider in Northern Ireland) Volunteer shift worker on the Street Injectors Support Service

5. Mr Mohammed Fessal

Chief Pharmacist, Change Grow Live (CGL)

Declaration of interests

• Specialist Advisor for the Care Quality Commission (CQC)
• Research grants for studies relating to opioid addiction from Indivior and Ethypharm

6. Dr Emily Finch

Clinical Director of the Addictions Clinical Academic Group and Consultant Psychiatrist, South London and Maudsley NHS Trust

Declaration of interests

• Joint chair of the London Joint Working Group (LJWG) on Hepatitis C which is part funded by Gilead Sciences, AbbVie and Merck Sharp & Dohme Limited (MSD)

7. Professor Sarah Galvani

Professor of Social Research and Substance Use, Department of Sociology, Manchester Metropolitan University

Declaration of interests

• International Editorial Board Member, Drugs: Education, Prevention, Policy
• Member, Griffin Schools Trust
• Founder and Co-Chair, Substance Use and Associated Behaviours Research Group (SUAB) Manchester Metropolitan University
• Member of Public Health England’s Mental Health Intelligence Network Dual Diagnosis Committee
• Research funding or knowledge exchange received from:
  • National Treatment Agency (now PHE)
  • Public Health England
  • Alcohol Research UK (now Alcohol Change UK)
  • Big Lottery Fund (now National Lottery Community Fund)
  • National Institute for Health Research
  • Cabinet Office
  • Home Office
  • Scottish Executive (now Scottish Government)
  • Comic Relief
  • Health Education North West
• Former Trustee – Alcohol Research UK (now Alcohol Change UK)
• Former Trustee – AVA (Against Violence and Abuse)
• Former Trustee – CADAS (Cumbria Alcohol and Drug Advisory Service)
• Former Chair and Founder – British Association of Social Worker’s Special Interest Group in Alcohol and other Drugs
• Former Trustee and Volunteer – Aquarius
• Former member of the Department of Health Applied Professions Advisory Group on Drug and Alcohol Strategy

8. Lawrence Gibbons

Head of Drug Threat (Intelligence Directorate, Commodities), National Crime Agency (NCA)

Declaration of interests

Nil

9. Dr Hilary Hamnett

Senior Lecturer in Forensic Science, University of Lincoln and Forensic Toxicologist

Declaration of interests

Nil

10. Professor Graeme Henderson

Professor of Pharmacology, University of Bristol

Declaration of interests

• Trustee, the Bristol Drugs Project
• Committee member, DrugScience
• Volunteer, Health and Harm Reduction Centre, Bristol Drugs Project
• Research funding received from:
  • Medical Research Council (UK)
  • National Institute on Drug Addiction (USA)

11. Dr Carole Hunter

Lead pharmacist, Alcohol and Drug Recovery Services NHS Greater Glasgow and Clyde and Doping Control Officer, UK Antidoping

Declaration of interests

• Member, Royal Pharmaceutical Society (RPS)
• Member, RPS Medicines, Ethics and Practice Guide Advisory Panel
• Chair, Scottish Specialist Pharmacists in Substance Use Group
• Member, Police Scotland Drug Strategy Group
• Royal Pharmaceutical Society representative, Drug Deaths Taskforce (Scotland)
• Member, Independent Expert Working Group, Drug Misuse and Dependence, UK Guidelines on Drug Misuse and Dependence (Orange Guidelines) 2017
• Former member, Drug Strategy Delivery Group (Scotland)
• Former Chair, National Naloxone Advisory Group (NNAG), Scotland

12. Professor Roger Knaggs

Associate Professor in Clinical Pharmacy Practice, University of Nottingham

Declaration of interests

• Secondment from University of Nottingham to Primary Integrated Care Solutions to provide clinical services.
• University department has received research funding from Mundipharma Research Ltd to support a PhD studentship (2016-present) on opioid use
• Honorary Secretary, British Pain Society (2016-2019)
• Vice President, British Pain Society (2019-2021)
• Joint editor, British Journal of Pain
• Member, Patient safety Controlled drugs subgroup, Care Quality Commission
• Member, Medicines Advisory Group, Faculty of Pain Medicine
• Group member, Pain management pharmacist group, UK Clinical Pharmacy Association
• Media spokesperson on pain management, Royal Pharmaceutical Society
• Guideline Committee member, NICE clinical guideline on chronic pain

13. Professor Tim Millar

Professor of Substance Use and Addictions, University of Manchester

Declaration of interests

• was a member of the organising committee for, and chaired, conferences supported by unrestricted educational grants from Reckitt Benckiser, Lundbeck, Martindale Pharma and Britannia Pharmaceuticals Ltd (unpaid)
• collaborates with the addiction treatment provider Change Grow Live (CGL) (unpaid)
• Speaker fees received from a commercial healthcare consultancy firm
• Research funding received from:
  • UK National Treatment Agency for Substance Misuse (now Public Health England)
  • Home Office

14. Mr Rob Phipps

Retired, Department of Health, Social Services and Public Safety in Northern Ireland.

Declaration of interests

• Member of the Northern Ireland Drinks Panel
• Former Head of Health Development Policy branch for alcohol and drug policy, Northern Ireland.
• Former board member of ‘Include Youth’

15. Harry Shapiro

Director, DrugWise

Declaration of interests

• Former Director of Communications and Information for DrugScope
• Secretariat for the All-Party Parliamentary Groups on Prescribed Drug Dependence
• Member of the Opioid Painkiller Dependence Alliance

16. Dr Richard Stevenson

Emergency Medicine Consultant, Glasgow Royal Infirmary

Declaration of interests

• Lead Medical Adviser for Clinical Governance for Police Scotland
• Special Constable, British Transport Police,

17. Dr Paul Stokes

Reader in Mood Disorders and Psychopharmacology, King’s College London and Honorary Consultant Psychiatrist South London and Maudsley NHS Foundation Trust

Declaration of interests

• Member of the Royal College of Psychiatrists Psychopharmacology committee
• Specialty Chief Editor for the Mood and Anxiety Disorders section of Frontiers in Psychiatry
• Research funding and related expenses received from Medical Research Council, National Institute for Health Research, Corcept Therapeutics, H. Lundbeck, Frontiers in Psychiatry
• Non-financial research support received from Janssen Research and Development LLC
• Honoraria received from Indivior, Liva Nova, Allergan and Frontiers in Psychiatry for lecturing, consultancy and editorial work

18. Dr Ann Sullivan

Consultant Physician in HIV and sexual health and national co-lead for HIV Surveillance, Public Health England (PHE)

Declaration of interests

• Former Trustee and Executive (Hon Secretary) of the British HIV Association
• Honorary Secretary European AIDS Clinical Society (EACS)

19. Professor Matt Sutton

Chair in Health Economics, University of Manchester and Professorial Research Fellow, University of Melbourne

Declaration of interests

• National Institute for Health Research Senior Investigator
• Member (and former joint National Organiser) of UK Health Economists’ Study Group
• Elected member of the European Health Economics Association Executive Committee
• Deputy Chair of the National Institute for Health Research Health Services and Delivery Research Funding Committee
• Member of the NHS England Advisory Committee on Resource Allocation
• Member of Department of Health Policy Research Programme Board
• Member of National Institute for Health Research Advanced Fellowships Panel
• Research funding received from;
  • National Institute for Health Research
  • Department of Health
  • European Union
  • Health Foundation
  • Medical Research Council
  • Innovate UK
  • Wellcome

20. Professor David Taylor

• Director of Pharmacy and Pathology, South London and Maudsley NHS Foundation Trust
• Professor of Psychopharmacology, Institute of Pharmaceutical Science, King’s College, London
• Honorary Professor, Institute of Psychiatry, Psychology and Neuroscience
• Head of Pharmaceutical Sciences Clinical Academic Group, King’s Health Partners

Declaration of interests

• Editor in Chief, Therapeutic Advances in Psychopharmacology
• Editorial board memberships (unpaid):
  • Acta Psychiatrica Scandinavica
  • Annals of General Psychiatry
  • CNS Drugs
  • Current Medical Research and Opinion
  • International Clinical psychopharmacology
  • International Journal of Clinical Practice
  • International Journal of Psychiatry in Clinical Practice
  • Journal of Psychopharmacology
  • Le Pharmacien Hospitalier et Clinicien
  • BJPsych Bulletin

21. Professor Simon Thomas

Consultant physician and clinical pharmacologist, Newcastle hospitals NHS Foundation Trust and Professor of Clinical Pharmacology and Therapeutics, Newcastle University

Declaration of interests

• Deputy Editor, Clinical Toxicology
• Chair, National Poisons Information Service (NPIS) Clinical Standards Group and Director, NPIS (Newcastle)
• Director, UK Teratology Information Service
• Member, Northern Treatment Advisory Group
• Member, Regional Medicines Optimisation Committee (Northern)
• Member, Ministry of Defence Advisory Group on Military and Emergency Response Medicine
• Deputy Director (Clinical), National Institute for Health Research funded Health Protection Research Unit for Chemical and Radiation Threats and Hazards
• Research funding received from;
  • Public Health England
  • National Institute for Health Research
  • Ministry of Defence
  • Epilepsy Research

22. Dr Derek Tracy

Consultant Psychiatrist and Clinical Director, Oxleas NHS Foundation Trust, Senior Lecturer, King’s College London and Visiting Senior Lecturer, University College London

Declaration of interests

• Consultant psychiatrist and Clinical director of Bexleycare, Oxleas NHS Foundation Trust
• Editorial board and social media lead of the British Journal of Psychiatry
• Executive member and quality improvement lead for the Academic Faculty of the Royal College of Psychiatrists
• Member of the National Institute for Health Research Dissemination Centre Advisory Group

23. Rosalie Weetman

Public Health Lead (Alcohol, Drugs and Tobacco), Derbyshire County Council

Declaration of interests

• Independent complaints panel member for the Portman Group, which evaluates code of practice violations relating to alcohol packaging, promotions and marketing
• Former specialist advisor to the Health and Social Care Select Committee’s inquiry on drugs policy

24. Dr David Wood

Consultant Physician and Clinical Toxicologist, Guys and St Thomas’ NHS Trust and Honorary Reader, King’s College London

Declaration of interests

• Expert advisor to
• United Nations Office on Drugs and Crime
• European Monitoring Centre for Drugs and Drug Addiction
• Funding/Grants received from:
  • United Nations Office on Drugs and Crime
  • European Monitoring Centre for Drugs and Drug Addiction
  • European Union
  • National Institute for Health Research
  • Researched Abuse, Diversion and Addiction-Related Surveillance (RADARS) system